The poster gives information about common dangers such as:
As well as focusing on common dangers, the poster also reinforces the importance of S.P.E.E.D when dealing with poisoned pets:
Will Peel, Product Manager at TVM UK said: "While most pet owners are mindful of the danger that certain foods and plants can pose, when you’re enjoying the spring sunshine and the long Easter weekend, it can be easy to overlook potential pet hazards. It’s vital to reinforce the dangers that can come with the warmer weather to help protect pets from poisoning which can cause serious illness or worse.’
To get your waterproof poster, contact your local TVM territory manager or email help@tvm-uk.com
The Disciplinary Committee took the unusual step of granting an application by the respondent for anonymity, after seeing evidence of a real and immediate threat to the individual’s security if their details were made public.
For the purposes of the hearing, the respondent was therefore referred to as 'X'.
The Committee heard that the individual pleaded guilty in court in 2020 to intentionally and knowingly attempting to communicate with a person under 16 years for the purposes of sexual gratification.
Following this they were sentenced to a two-year probation order, were ordered to register on the Sexual Offences Register for five years; and were made subject to a Sexual Offences Prevention Order for five years.
At the outset of the hearing the individual admitted to all the charges against them and the Committee also noted that there was a certified copy of the conviction available.
The Committee then considered whether the conviction amounted to serious professional misconduct. In considering this, it set out the aggravating factors surrounding the case, these being that there was the risk of actual harm to a minor, that the misconduct was premeditated as the respondent had sent a number of messages via a number of online platforms over several days, that the individual displayed predatory behaviour including sending pictures and making comments of a sexual nature, and that it involved what the respondent believed to be a vulnerable individual, namely a 15-year-old child.
In mitigation, the Committee considered that there had been no actual harm caused to a human or animal in light of the fact that the 15-year-old child, who the respondent believed they were communicating with, was not real. It also took into account that the conduct related to a single isolated incident and that the individual had made open and frank admissions at an early stage.
Cerys Jones, chairing the Committee and speaking on its behalf, said: “The Committee was satisfied that the sentence imposed on X, which included X being subject to a Sexual Harm Prevention Order until 2025, resulted in the profession of veterinary nurses being brought into disrepute and, in the Committee’s judgement, public confidence in the profession would be undermined if the Committee did not find that the conviction rendered X unfit to practise as a veterinary nurse.”
In considering the individual’s sanction, the Committee heard from a character witness who said that the respondent’s actions were out of character, that they had a previously long and unblemished career, that they had made full admissions and demonstrated insight, and that they had a low risk of reoffending in the future.
Cerys said: “The Committee accepted that X had been an excellent veterinary nurse and that X’s criminal conduct did not relate to X’s practice as a veterinary nurse. However, in the Committee’s judgement, the aggravating factors outweighed the considerable mitigating factors in this case.”
She added: “The Committee decided that a suspension order was not the appropriate sanction for such a serious offence because it did not reflect the gravity of X’s conduct. In the Committee’s judgement, the wider public interest, that is the maintenance of the reputation of the profession and the College as a regulator, required a sanction of removal from the Register. The Committee considered that X had much mitigation and was clearly a dedicated veterinary nurse but the reputation of the profession was more important than the interests of X.
“Further, the Committee noted that in circumstances where X’s probation order expired in 2022, and where the ancillary orders, a Sexual Harm Prevention Order and a requirement to register on the Sexual Offences Register did not expire until 2025; the only proportionate sanction was to direct the Registrar to remove X’s name from the Register of Veterinary Nurses.”
The full findings for the case can be found at: www.rcvs.org.uk/disciplinary
The study titled “Diagnosis and treatment of gastro-oesophageal junction abnormalities in dogs with brachycephalic syndrome” included thirty-six client-owned brachycephalic dogs (French bulldogs, pug and English bulldogs) in a prospective, randomised trial.
Antacid treatment (omeprazole (1mg/kg PO q24 hours) and magaldrate (5-10mL/dog PO q8-12 hours)) was randomly prescribed in 18 dogs before and after surgery, while the other 18 dogs did not receive any gastrointestinal medical treatment.
Digestive clinical signs and gastro-oesophageal junction abnormalities (GJA) were assessed and scored at presentation, at the time of surgery and at recheck. GJA were assessed during endoscopy in standard conditions, as well as during endotracheal tube obstruction. All endoscopic procedures were recorded and reviewed by a single, blinded reviewer.
In order to assess whether endotracheal tube obstruction manoeuvre accurately detects GJA, the procedure was also performed during the examination of the gastro-oesophageal junction in a group of 10 control dogs. Control dogs were healthy or had diseases that were not expected to interfere with gastro-oesophageal junction dynamics, and were anaesthetised for independent purposes.
Dr Emilie Vangrinsven, corresponding author for the paper said: "Although results of multivariate analysis failed to demonstrate a direct effect of antacid treatment, a significant interaction between antacid treatment status and improvement of digestive clinical score throughout the endoscopies was present, meaning that treated animals seem to improve faster and have lower clinical scores after surgery than untreated animals. Furthermore, a significant improvement in GJA-obstruction score was present in the treatment group only.
"In contrast to standard endoscopy, the obstruction manoeuvre during endoscopy allowed detection of GJA in dogs, even in the absence of clinical signs. We were concerned that the obstruction manoeuvre may induce false positive results for the diagnosis of dynamic GJA; in the control group, GJA during obstruction manoeuvre were found to be negligible suggesting that this technique does not significantly overestimate the presence of GJA.”
Nicola Di Girolamo, Editor of JSAP said: "Based on this study, antacid treatment administered to brachycephalic dogs undergoing surgery may be beneficial. It should be noted that a direct influence of antacid treatment on digestive clinical and lesion scores could not be significantly demonstrated, which may have been because of the lack of an actual difference, or as a result of the small sample size.”
The full article can be found in the March issue of the Journal of Small Animal Practice and can be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13279
Reference
Photo: Professor Ian Ramsey
Until now, the treatment has only been available in 20 and 40 pack sizes. The new two-tube pack option offers clients a pre-packaged treatment course for one ear.
Dechra Brand Manager Carol Morgan said: “The introduction of a pre-packaged Osurnia treatment course provides a convenient solution to veterinarians treating otitis. Osurnia comes in pre-measured, single-dose tubes of the gel with a soft flexible applicator tip that ensures the dog receives the right dose, every time, all while minimising discomfort for the patient.
"The patented gel formulation provides reassurance that the solution is less likely to be dislodged from the patient’s ear, prolonging the contact of the active medicines directly at the infection site1.
"A treatment plan using Osurnia means that vets can help ensure compliance of treatment. The application of the second dose provides an additional opportunity to assess the patient to ensure it is responding as planned."
Osurnia two-tube packs are available from wholesalers. For more information, visit: www.dechra.com.
The PIC decision marked the conclusion of its investigation into a concern that was raised formally last November involving allegations of bullying at Professor Argyle’s workplace, the University of Edinburgh.
Professor Argyle, who had previously decided to step aside from his JVP and Council duties until the concern was investigated and concluded, said: “Despite this outcome from the PIC discussions, I have now made the challenging decision to stand down from my position at the RCVS. This is to ensure there is no further distraction to the College’s important work and activities and that whoever becomes the next JVP has the full support of Council and RCVS members.
"It is also to reduce the toll this situation has taken on my family, colleagues and students, and on me personally. I am proud and privileged to have served on RCVS Council for nearly ten years and wish it well as it navigates the next chapter in its history."
RCVS President Mandisa Greene said: “I appreciate that this has been an exceptionally difficult situation and very upsetting for all involved.
"I understand why David has taken the difficult decision to stand down from RCVS Council and would like to thank him for his many years of service to the RCVS since joining Council in 2012.
"I would also like to reassure colleagues once again that, throughout, the College has remained firmly committed to following due, proper and fair process in all its regulatory activities."
Following Professor Argyle’s decision to step down, the process for electing a new JVP for the current presidential year will commence.
As Professor Argyle was a Veterinary Schools Council appointee on RCVS Council, it will be for that body to elect a replacement Council member.
Further details will be announced in due course.
The gallery was traditionally held in-person at the NAVC’s annual Veterinary Expo & Meeting (VMX) in Florida.
Now, for the first time since it began in 2012, the gallery is accessible to everyone everywhere months before the live event in June.
The new Virtual VMX New Product Gallery went live this week and will run until 3rd September 2021. It showcases 21 new product innovations from the following companies: BioNote; Boehringer Ingelheim Animal Health; Dechra Veterinary Products; Epicur Pharma; GVL; Hill’s Pet Nutrition, Inc.; Merck Animal Health; Neogen Corporation; Ogena Solutions; Purina; Royal Canin; Vetoquinol; Zoetis Petcare.
NAVC CEO Gene O’Neill said: "Each year, NAVC’s panel of experts select the most innovative new products and services to be showcased as part of the VMX Expo. We are excited to take this VMX staple and, for the first time, make it universally available to members of our global veterinary community everywhere.
"And they don’t have to wait until June to learn about and try these important new products. The VMX Virtual New Product Gallery launch is part of the NAVC’s expanding virtual portfolio which breaks down barriers of geography and time to make the best products the veterinary industry has to offer available to veterinary professionals worldwide.” The gallery is free to access. You can register here: https://vmxvirtual.simexpo.com/page/100
The new programme, which starts in May 2021, will address the fundamental principles underlying cardiac disease, discuss common presentations and review current diagnostic and therapeutic techniques.
Modules are delivered using a range of blended learning techniques, including interactive online lessons, supported by notes and videos.
While studying, delegates will have a module tutor – a recognised veterinary Specialist in their field - and a dedicated programme tutor, who works with individual delegates to support them through the programme.
Delegates can also choose three optional practical attendance sessions covering ECGs, thoracic radiography and echocardiography.
The programme offers a route through to achieving academic qualifications - General Practitioner Certificate (GPCert) and the Postgraduate Certificate (PgC), in partnership with the International School of Veterinary Postgraduate Studies (ISVPS) and Harper Adams University. Gaining a PgC enables delegates to apply to RCVS for Advanced Practitioner status in the subject.
Course Director Kieran Borgeat BSc BVSc MVetMed CertVC DipACVIM DipECVIM-CA MRCVS, said: "Improve International’s Cardiology DL programme features a diverse array of speakers from a variety of backgrounds, who will bring the latest information about veterinary cardiology to delegates. Our module leaders are world experts in their field so bring a thorough and uniquely engaging approach to the course material. Being able to discuss the topic with them and other course delegates online during each module of teaching during a two-year, in-depth course is a fantastic opportunity to connect with the topic as never before."
David Babington MRCVS, Business Development Director at Improve International, said: “Our cardiology programme has been designed to equip delegates with all of the skills and knowledge they need to confidently investigate, diagnose and treat cardiac patients.
“As we start to look ahead to a time beyond lockdowns, many veterinarians are taking stock and considering the next step in their career. For some, an additional qualification may be part of their plan. By offering a distance learning solution, we can ensure that, wherever in the world they are in practice, they have the opportunity to develop their clinical skills and achieve a postgraduate qualification.”
Registration information can be found here: https://www.improveinternational.com/uk/course/pgc-gpcert-small-animal-cardiology-distance-learning/
Rexxolide contains 100 mg/ml of tulathromycin, which is widely used to treat BRD and SRD. It also has a single dose and low injection volume of 1 ml/40 kg BW, to make it more convenient.
Dechra says Rexxolide has an immune-modulating and anti-inflammatory action and offers equal viscosity and syringability as other products on the market1. It can be used for treatment and metaphylaxis of BRD and SRD and offers early-stage treatment for infectious pododermatitis.
Dechra’s Equine and Food Producing Animal Brand Manager, Emma Jennings said: “Launching Rexxolide into the market provides an alternative option to existing BRD, SRD and foot rot treatments for farm vets across the UK and Ireland.
"We support an integrated approach to the control of BRD, with good husbandry, early detection and correct therapy being vital tools in managing the multi-factorial condition."
Rexxolide is available in 50ml and 100ml vials. For more information visit www.dechra.co.uk.
The academy will consist of three modules which will be launched in 2021. Those who complete all three modules will receive certification from Bimeda, and some exclusive branded goodies.
The first module is titled Bimeda Trace Elements in Dairy Cow Fertility & Pregnancy and is available now on Bimeda’s e-learning portal: https://bimeda-learning.co.uk. This module also accounts for 1 hour 15 minutes of CPD and vets can download a certificate when they complete the module. The module has also been accredited with 9 AMTRA points.
In the coming months Bimeda says it'll add a second module focused on the role of trace element nutrition in lamb and calf growth, and a final module focused on the role of trace elements in sheep fertility and pregnancy.
Bimeda UK General Manager Mark Cokayne said: "Trace elements play a critical role in the health and fertility of ruminants, yet historically this area has been somewhat overlooked in formal animal health education.
"Our customers tell us that they would like a deeper understanding of areas such as trace element deficiencies, toxicities and interactions, and the impact of these on ruminant health and fertility. We are pleased to respond to this market demand with our new academy, which will provide veterinarians and SQPs with additional knowledge to help inform their conversations with farmers."
To sign up to either Bimeda’s online Nutrition Academy or the Sheep Scab Academy, visit https://bimeda-learning.co.uk
For more information, speak to your Bimeda territory manager or call Bimeda on 01248 725 400.
There are 14 candidates standing in this year’s election, including one current RCVS Council member eligible for re-election and 13 candidates not currently on Council. They are:
In 2018 changes were made to the governance arrangements of the RCVS after a Legislative Reform Order changing the size and composition of Council was passed by Parliament. The changes mean that, in most years, there will be three elected places available for the candidates. However, this year the four candidates with the most votes will be starting their four-year terms on Council. This is to ensure that elected RCVS Council members remain in the majority.
Emails containing links to the secure election voting websites which are unique to each member of the electorate, were sent on 17 March 2021 by Civica Election Services (CES) (formerly Electoral Reform Services) which runs the election on behalf of the College.
All votes must be cast online by 5pm on Friday 23 April 2021. The small numbers of veterinary surgeons for whom the RCVS does not hold email addresses have been sent letters in the post containing instructions on how they can vote online, including contact details for CES to provide further advice.
The biographies and statements for each candidate can be found at: www.rcvs.org.uk/vetvote21.
This year the College invited RCVS Council candidates to produce a video in which they answered up to two questions submitted directly to the RCVS from members of the electorate. The videos have been published on the RCVS website as well as on the RCVS YouTube channel (www.youtube.com/rcvsvideos).
In a 2019 BVA Voice of the Veterinary Profession Survey, 89% of vets said that they would like to play a more active role in the UK sustainability agenda.
The new checklist includes four major areas for action that cover practising responsible resource use, being sustainable in your operation, using medicines responsibly, and sustaining the team. Each theme has a list of ways that these actions can be achieved.
Vet Sustain founder and director, Laura Higham said: "Veterinary professionals and members of the vet-led team are extremely well positioned to show leadership in sustainability, in their workplaces and in their communities.
"Our new checklist helps veterinary teams to put their sustainability intentions in to practice, through a number of practical steps that will ultimately support the wellbeing of our patients, ourselves and the natural world."
BVA Junior Vice President, Justine Shotton said: "We know that lots of our members are passionate about the environment, and the ‘Greener Veterinary Practice Checklist’ is a great place to start for any veterinary team wanting to work in a more environmentally friendly way.
Jo Oakden RVN BVNA President said: "Environmental Sustainability is really important to us at the BVNA; we are currently going through the process of Environmental Accreditation. Veterinary Nurses are ideally placed to get involved and drive eco-friendly changes within the veterinary practice."
For more information, visit: https://vetsustain.org/
VetCT says the app, which offers round the clock, rapid access to specialist support, aims to bridge the existing gap for those clinical cases where specialist input is desired, but for which full referral may not be ideal or possible.
It is also hoped that the new service will reduce the amount of time that GPs currently have to spend seeking further clinical advice, currently estimated at 10 hours per week, and reduce the amount of advice that Specialists currently give for free, estimated at 5 hours per week.
Using the app, GPs can send all the relevant information for the consultation, including the history, test results, videos and photos to Diploma-holding specialists across the entire range of specialties, direct from their mobile phone.
They can then choose whether to get an immediate call-back or text chat, a written report or a virtual appointment.
Victoria Johnson, co-Director, said: “Our mission is to help every vet be the best and feel their best every day. Behind the app we have a committed team of over 50 employed specialists, plus 100 radiologists and a full customer support team ready to respond to enquiries.
"All our specialists also work in clinical roles and previously have worked in first opinion practice, and we have so much respect for the challenges our general practitioner colleagues face.
"We want to make their lives that little bit easier, supporting them – with empathy – in giving the best care to complex cases where referral may not be an option.
"We also want to provide pet owners with access to specialist care for their pets, where cost or travel may preclude them from seeing a specialist at a referral centre.”
In addition to the consultation fee, there's an annual practice membership fee of £200 which is reduced for locum vets. VetCT says practices may choose to charge fees on to clients, or some practices may decide to absorb the costs for the support value it offers their clinicians.
VetCT says it will also gifting additional credits to help support vets who may benefit from a helping hand, such as those returning from extended leave, moving to different species areas, or new graduates.
The service is designed to complement existing specialist services. Victoria added: “We recognise the vital importance of physical referrals, and this service in no way replaces that. Indeed, we have started to see evidence that using the app will lead to more patients getting physically referred for the right reasons, at the right time, with the right information.
"However, we also know that many vets and specialists are under huge time pressure. Many specialists felt they were unable to do a good job of dealing with advice queries alongside their busy day job – much as they wanted to help. We hope this app relieves the pressure for both parties, provides fast, exceptional and supportive specialist advice, and increases the number of pets and owners who can benefit from specialist input."
The new app, which will be available for both IOS and Android, will launch at BSAVA Congress 2021, with pre-registration available prior to the launch on 25th March.
To discuss rates and credit options, email: info@vet-com.com.
The study1 was led by the RVC’s VetCompass programme and included 22,333 dogs whose health was followed for a year, during which 1,580 were recorded by the vet as overweight; roughly 1 in 14.
The authors point out that this figure is probably just the tip of the iceberg, because not every overweight pet will receive veterinary attention.
The study also found that certain breeds were especially prone to weight gain, including Pugs, Beagles, Golden Retrievers and English Springer Spaniels.
As well as showing that specific breeds were at differing risk, the study also highlighted that being neutered and middle-aged were additionally associated with increasing chances of dogs being overweight.
The main findings were:
Owners are encouraged to discuss their dog’s weight and lifestyle on every visit to their veterinary practice. This is of particular importance in the high-risk dogs identified in this study such as Pugs, Beagles, neutered and middle-aged dogs.
Camilla Pegram, VetCompass Epidemiologist at the RVC, and author of the paper, said: "This study has used the power of “big data” to robustly address the risk factors for obesity in dogs. Pugs, Beagles and Golden Retrievers were at greatest risk of obesity compared with crossbreeds.
"As well as genetics, management style could in part drive these breed predispositions. Whilst veterinary professionals and owners should focus efforts on obesity prevention strategies in all dogs, those identified at high-risk, such as Pugs, Beagles and Golden Retrievers, may need a more targeted approach."
Dr Eleanor Raffan, Associate Lecturer in Systems Physiology, at the University of Cambridge, and co-author of the paper, said:
“Where breed increases risk of a problem, it means genes are likely to be at least in part to blame and our previous work suggests that genetics drives a high appetite in some breeds. The bad news is that owners of food-obsessed dogs have to work much harder to keep their dogs at a healthy weight – the good news is that it can be done.”
Newmarket-based Test and Treat was one of three finalists, for its U-Treat test which enables vets to diagnose a UTI and get antibiotic sensitivity results in an hour.
Rachel Kirkby MRCVS, Business Development Director at Test and Treat, said: "It’s a great accolade to be recognised by such a prestigious award. The Vet Record Innovation Award celebrates new innovations that can bring about improvement and make a real difference to vets in practice – and that’s exactly what we’re aiming to do with U-Treat.”
The second finalist was the Animal Welfare Assessment Grid, developed by Public Health England (PHE), in collaboration with the University of Surrey School of Veterinary Medicine. Initially developed in zoos, rescue and research centres, there are plans now to develop it for use in small animal practice and in the farm sector.
The overall winner was PBD Biotech for Actiphage, its test for bTB and Johne's disease which gives very early detection, thereby allowing vets and farmers to prevent the spread of infection.
For more information, visit: https://bvajournals.onlinelibrary.wiley.com/doi/10.1002/vetr.267
Melissa graduated from the University of Glasgow in 1987 and, after working as a food animal intern at Iowa State University in the United States for a stint, in 1990 joined a two-person traditional mixed-animal veterinary practice on the Ayrshire coast. Over the next 25 years she developed it into a 4.5 person small-animal practice with a focus on dentistry, before moving away from clinical work in 2015.
Melissa was first elected to Council in 2016 and re-elected in 2020 and, since joining, has sat on a number of committees including the Education Committee, Finance & Resources Committee, and Preliminary Investigation Committee/Disciplinary Committee Liaison Committee. Since 2019 she has chaired the Standards Committee where she has led the Review of ‘Under Care’ and Out-of-Hours Emergency Cover and also chairs the Certificate in Advanced Veterinary Practice Subcommittee.
As well as her work with RCVS she has also been President of the British Veterinary Association’s Scottish Branch and is currently a Non-Executive Director of the Red Tractor Assured Food Standards Scheme and a Trustee of the Scottish Society for the Prevention of Cruelty to Animals. Outside of work, she enjoys running, swimming, cooking, reading and hopes to have the patience one day to write children’s books.
Melissa said: “I’m delighted and humbled to have been voted in as JVP from July. Thank you to my peers on Council and, as with everything I have done in my career, you, the profession, will see me put all my energy and commitment into the role.
"Themes that I'm keen to develop as a member of the RCVS Officer Team will be: communication, as that can always be improved; community, including within the profession, within the workplace and within the society in which you live; and continuing with the ‘blame culture’ theme originally set out in Chris Tufnell's presidency by looking into how we can use veterinary human factors to improve patient safety."
Other appointments that were confirmed by election at the same meeting of Council was Dr Niall Connell MRCVS as RCVS Treasurer, a role he will take up at the July AGM after completing his year as Senior Vice-President.
Niall: “It is a tremendous honour for me to be elected Treasurer. The RCVS has an exciting strategy which I am looking forward to playing my part in ensuring we remain on a sound financial footing, supporting projects within the RCVS Strategic Plan and continuing to play a wider role within the RCVS Officer Team.”
In terms of committee chairs, Dr Sue Paterson FRCVS was reconfirmed as Chair of the Education Committee, Dr Melissa Donald was reconfirmed as Chair of the Standards Committee and current RCVS President Dr Mandisa Greene MRCVS was elected as Chair of the Advancement of the Professions Committee, replacing Professor David Argyle in that post from July 2021.
Following Professor Argyle stepping down as Junior Vice-President earlier in March 2021, an election to replace him as Junior Vice-President for the remainder of the presidential year will take place in April 2021. Subject to the usual approval from Council, this person will take up the position of RCVS President 2021-22 following the AGM in July.
Cosacthen contains 0.25 mg/ml of tetracosactide which had only previously been available as human-registered or compounded veterinary ‘special’ preparations meaning availability and cost could be unpredictable.
Tetracosactide is used in the ACTH stimulation test to assess the adrenocortical function of patients with endocrine diseases, such as Cushing’s and Addison’s.
Dechra Brand Manager Claire Morgan said: “As experts in endocrinology, we recognise that the testing involved in adrenal conditions can be a costly process for pet owners, which can mean that some cases don’t progress to treatment or have their treatment optimised.
"The launch of Cosacthen gives veterinary surgeons the reassurance associated with a veterinary licensed medicine. As these cases can appear on an irregular basis, Cosacthen is ideal to keep in the practice ready for when a case is presented making it a cost-effective solution that can help offset the cost for owners of long-term treatment of adrenal conditions."
Cosacthen is available in 1 ml single-use vials.
For more information visit www.dechra.co.uk/cosacthen.
The new guidance, which can be found at www.rcvs.org.uk/coronavirus, will gradually replace the current emergency guidance and aims to help veterinary practices begin a phased return to near-normal operations:
Alongside the College’s guidance, the BVA is also publishing guidance for practices on working safely as lockdown restrictions are eased. [www.bva.co.uk/coronavirus/]
RCVS President Mandisa Greene said: “None of us could have predicted quite what an extraordinary and extraordinarily challenging 12 months this has been for everyone.
"On behalf of the whole of RCVS Council, I would like to thank sincerely once again all our veterinary and veterinary nursing colleagues, and all those in practice teams around the UK, for their awe-inspiring commitment, adaptability, resilience and sheer hard work in continuing to provide essential veterinary services and look after the health and welfare of the nation’s animals, in what have been the most difficult of times.
“Whilst I sincerely hope that we are at last beginning to see light at the end of the tunnel, if there is one thing we have learnt, it is that things can deteriorate rapidly if we don’t all continue to play our part and follow all relevant guidelines.
“I therefore urge my colleagues to continue to use their professional judgement and think very carefully about their gradual return to more normal working patterns over the coming weeks and months, according to their individual circumstances and the best interests of their teams, clients, and the animals they care for.”
RCVS Council has also agreed that the policy and guidance changes made in response to the pandemic over the past 12 months will now be reviewed, and decisions made as to whether to retain, amend or reverse them.
Cryptisel is for use in reducing oocyst shedding in calves where diarrhoea caused by Cryptosporidium is a problem. After the presence of the causal organism has been established, Forte says Cryptisel can be used in all new-born calves to break the cycle of transmission and multiplication on-farm.
Dr John Henderson, Large Animal Product Manager with Forte Healthcare Ltd said: "Cryptisel will be a very useful medicine in the control of the most commonly-identified scour pathogen in the UK and Ireland. Used alongside the calf-rearing cornerstones of good colostrum management, hygiene, and biosecurity, Cryptisel will reduce production of Cryptosporidium oocysts and help limit spread of the disease among susceptible calves."
Cryptisel is a POM, available in 490ml and 980ml bottles. Both sizes come with a metered dosing pump for convenient administration.
For further information, contact your local Forte Territory Manager or email enquiries@fortehealthcare.com.
201 practices took part in the survey between 25th February and 4th March 2021. The main findings were:
Lizzie Lockett, RCVS CEO, said: “Although this survey took place in the midst of the lockdown and before the schools re-opened, there were some positive results here around staffing and the financial situation for practices. Hopefully this will mean that, as the restrictions ease going from spring into summer, many practices and practice staff will be in a position to return to a near-normal level of service and business.
"There were, however, still a few areas of concern, some of which will hopefully be resolved by the forthcoming easing of restrictions, for example, the difficulty in obtaining independent witnesses for the destruction of controlled drugs, with some 34% of practices reporting difficulties, compared to 20% in December.
“Once again, I would like to thank all those practices who responded to this and previous surveys, and continue to provide invaluable evidence and feedback about the current state of veterinary practice.”
The full results of the survey can be downloaded at: www.rcvs.org.uk/publications
The new course is called ‘New staff training course with Post2Pet’, and, as the name suggests, it will look at how to incorporate the home delivery option into a preventative healthcare plan.
Premier Vet Alliance says the course is suitable for any member of the practice team that wants to increase their knowledge about healthcare plans.
The course is 4 modules long with an assessment leading to 1.5 hours of completed CPD. It will launch towards the end of April.
James Tudor, Head of Customer Experience at Premier Vet Alliance, said: "This is a fantastic resource and I am I so proud of the team who’ve developed this and helped practices to train staff efficiently and effectively.
"It’s opening up the future of training and we hope to gain guidance in developing our training provision by working directly with practices, to help keep the training relevant.
"We see real value in CPD accredited courses, especially where they help enable veterinary staff to increase their knowledge on maximising their clients’ compliance. They can also learn how to influence animal health, and drive other aspects of the business through health plans."
"This is just the beginning; we will continue to increase our CPD accreditations and share best practice across Europe and the United States."
For more information contact 0117 370 0300 or email pcp@premiervetalliance.co.uk .
The deal includes an option for the College to lease the building for up to two years to give it time to consider its options for the future, and how they may have changed as a result of the pandemic.
The decision to sell the property was made back in November 2018, when Council decided that the building was rapidly becoming unfit for purpose and the College needed more up-to-date and modern facilities with more room for a growing workforce. The College’s Estates Strategy Project Board was tasked with managing the process, chaired by former RCVS President Barry Johnson.
RCVS Treasurer Susan Dawson said: “Council recognised that this deal realised maximum value for the building, especially considering the impact the pandemic has had on property prices in Central London.
“It also provides a very valuable opportunity to reflect on the changing needs of the organisation and the professions and public it serves, and to consider the requirements and different working patterns of the College staff going forwards.
“It is likely that many staff members will wish to continue to work at home more than they did pre-Covid, so the need for pure desk-space may not be as great as we had planned for the 10-15 years ahead. However, the importance of in-person meetings for collaboration, creativity and the maintenance of good corporate culture is not to be underestimated, so our new requirements are likely to be different to that anticipated back in 2018.”
The College says it expects to welcome limited numbers of staff back to the office in June, to work in a socially distanced way, including virtual or partly-virtual meetings.
Changes to working patterns over the coming months will also help inform decisions around future remote working policies and the type and size of building that will best suit the future needs of the College and its workforce.
Apovomin is effective after a single injection, with results in two to fifteen minutes.
Apovomin has the active substance apomorphine hydrochloride hemihydrate 3 mg (equivalent to apomorphine 2.56 mg). It is being marketed in 5 ml vials. It has a three-year shelf life and lasts for up to 28 days once broached.
Dechra Brand Manager Claire Morgan said: “Unfortunately there are many everyday substances that are toxic to dogs once ingested and time is of the essence when dogs have swallowed something that is poisonous to them.
“It is vital that veterinary professionals have access to a safe and effective treatment like Apovomin that they know they can rely on when dealing with cases like this.
“Apovomin offers a cost effective and successful treatment for accidental poisoning that will be an important tool for veterinary professionals in day-to-day practice.”
For more information visit www.dechra.co.uk.
The company says that despite the development of alternatives to natural bone grafting, such as allografts and synthetic products, autologous bone graft is still considered the standard. However, it has a number of disadvantages, such as donor site morbidities and lameness, limited availability of graft volume (particularly in small size pets) and additional surgical time.
Biocera-Vet is a new bone substitute indicated in surgical procedures where bone grafting is necessary, such as arthrodesis, complex fractures, corrective osteotomy used in correction of limb deformities or as add-on to Tibial Tuberosity Advancement (TTA).
Biocera-Vet is an injectable synthetic self-hardening calcium-phosphate cement combining osteo-inductive, osteo-conductive and osteo-integrative properties designed to support a fast and strong consolidation.
TheraVet says Biocera-Vet also presents an excellent safety profile thanks to its biocompatibility, reduced comorbidities and superior ergonomics which save a significant amount of surgical time.
Dr Olivier Stiévenart, an orthopaedic veterinary surgeon at Surgivet in Belgium said: "Using Biocera-Vet has enabled us to optimise our patient care considerably, by reducing the operating time by at least 30 minutes. The use of an efficient and rapid bone substitute represents a real progress in terms of both operations and the animal’s quality of life".
Julie Schurgers, Chief Commercial Officer of TheraVet, said: "Biocera-Vet is a unique product on the veterinary bone substitute market, combining outstanding bone consolidation properties with an excellent safety profile and superior ergonomics. We are very excited today to announce its commercialisation on the market and are convinced that this innovative product will significantly improve the daily practices of veterinarians, for the well-being of patients and their owners."
The product is now available in Belgium, and will be rolled out in France and the Netherlands shortly, with the rest of Europe following later in 2021 / 2022.
For more information, visit: https://www.thera.vet/en/biocera-vet
To nominate someone for inclusion in the showcase, visit: https://www.beva.org.uk/60-Faces
BEVA President Lucy Grieve said: "We are proud of BEVA’s heritage and want to recognise our 60th birthday by celebrating some of those who have made a significant difference to the equine veterinary community. We want you to help us identify the 60 individuals who you believe have truly inspired, influenced and progressed the equine veterinary profession for the better.”
Each of the nominated 60 faces will be highlighted on the website and on BEVA’s social media channels. Profile details will include career paths, workplaces and personal contributions to the equine veterinary profession.
Lucy added: "We have already started the list with Colonel John Hickman, Sue Dyson and Peter Rossdale. But there are hundreds of exceptional, deserving individuals who have made a huge difference to the equine veterinary profession and are worthy of our 60 Faces roll call."
The deadline for nominations is Friday 16th April 2021. All nominations are anonymous.
In the study titled 'Staphylococcal bacterial contamination of portable electronic devices in a large veterinary hospital1', samples were taken from the screen and any button of PEDs (such as mobile phones and tablets) of staff working directly with feline and canine patients. Hospital staff were asked to complete a questionnaire to ascertain the frequency of PED use and the frequency and method of PED cleaning.
The aim of the study was to determine the prevalence of Staphylococcal contamination of PEDs in a veterinary hospital, and to identify the source and determine the pathogenesis of any cultured strains.
Positive cultures were tested for resistance to oxacillin and vancomycin using a Kirby-Bauer disc diffusion test and then by using a broth microdilution test to EUCAST guidelines and breakpoints. PCR was used to specifically genotype the isolated staphylococci.
Georgia Vinall, corresponding author for the paper, said: “Useable swab samples were taken from 47 devices. Staphylococcus spp. were cultured from 68% of PEDs with a median of 10 colonies grown per device. Vancomycin-resistant Staphylococcus spp. were found on 36% of devices, whilst oxacillin-resistant Staphylococcus spp. were cultured from 2% of devices. DNA sequencing identified three Staphylococcus species; S. capitis, S. epidermidis and S. hominis which are most likely associated with humans as either sources or transmission vectors."
“The results of the survey indicate that 96% of staff had a PED which they used in the hospital environment, of which 85% use their device every day. Despite the high usage of PEDS in the hospital environment, only 6% of staff cleaned their device daily, with 33% of staff cleaning their PED less than weekly. Furthermore, only 54% of staff cleaned their device with a disinfectant."
Nicola Di Girolamo, Editor of JSAP said: "This study demonstrates that PEDs may become contaminated with potentially pathogenic microorganisms. Although this specific study did not focus on transmission of these microorganisms, and therefore it is unclear what are the clinical implications of this finding, it seems prudent to develop appropriate protocols for cleaning of PEDs in veterinary hospitals."
The full article can be found in the April issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13289.